Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.

Zonulin is the only physiological mediator known to regulate intestinal permeability reversibly by modulating intercellular tight junctions. To investigate the relationship between intestinal permeability and obesity-associated metabolic disturbances in humans, we aimed to study circulating zonulin...

Full description

Bibliographic Details
Main Authors: José María Moreno-Navarrete, Mònica Sabater, Francisco Ortega, Wifredo Ricart, José Manuel Fernández-Real
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3356365?pdf=render
_version_ 1828374090674601984
author José María Moreno-Navarrete
Mònica Sabater
Francisco Ortega
Wifredo Ricart
José Manuel Fernández-Real
author_facet José María Moreno-Navarrete
Mònica Sabater
Francisco Ortega
Wifredo Ricart
José Manuel Fernández-Real
author_sort José María Moreno-Navarrete
collection DOAJ
description Zonulin is the only physiological mediator known to regulate intestinal permeability reversibly by modulating intercellular tight junctions. To investigate the relationship between intestinal permeability and obesity-associated metabolic disturbances in humans, we aimed to study circulating zonulin according to obesity and insulin resistance. Circulating zonulin (ELISA) was measured in 123 caucasian men in association with inflammatory and metabolic parameters (including minimal model-measured insulin sensitivity). Circulating zonulin increased with body mass index (BMI), waist to hip ratio (WHR), fasting insulin, fasting triglycerides, uric acid and IL-6, and negatively correlated with HDL-cholesterol and insulin sensitivity. In multiple regression analysis, insulin sensitivity (p = 0.002) contributed independently to circulating zonulin variance, after controlling for the effects of BMI, fasting triglycerides and age. When circulating IL-6 was added to this model, only BMI (p = 0.01) contributed independently to circulating zonulin variance. In conclusion, the relationship between insulin sensitivity and circulating zonulin might be mediated through the obesity-related circulating IL-6 increase.
first_indexed 2024-04-14T07:28:11Z
format Article
id doaj.art-5c7c66dd527746a59e8cc3d15ff664aa
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T07:28:11Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-5c7c66dd527746a59e8cc3d15ff664aa2022-12-22T02:05:56ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3716010.1371/journal.pone.0037160Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.José María Moreno-NavarreteMònica SabaterFrancisco OrtegaWifredo RicartJosé Manuel Fernández-RealZonulin is the only physiological mediator known to regulate intestinal permeability reversibly by modulating intercellular tight junctions. To investigate the relationship between intestinal permeability and obesity-associated metabolic disturbances in humans, we aimed to study circulating zonulin according to obesity and insulin resistance. Circulating zonulin (ELISA) was measured in 123 caucasian men in association with inflammatory and metabolic parameters (including minimal model-measured insulin sensitivity). Circulating zonulin increased with body mass index (BMI), waist to hip ratio (WHR), fasting insulin, fasting triglycerides, uric acid and IL-6, and negatively correlated with HDL-cholesterol and insulin sensitivity. In multiple regression analysis, insulin sensitivity (p = 0.002) contributed independently to circulating zonulin variance, after controlling for the effects of BMI, fasting triglycerides and age. When circulating IL-6 was added to this model, only BMI (p = 0.01) contributed independently to circulating zonulin variance. In conclusion, the relationship between insulin sensitivity and circulating zonulin might be mediated through the obesity-related circulating IL-6 increase.http://europepmc.org/articles/PMC3356365?pdf=render
spellingShingle José María Moreno-Navarrete
Mònica Sabater
Francisco Ortega
Wifredo Ricart
José Manuel Fernández-Real
Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
PLoS ONE
title Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
title_full Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
title_fullStr Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
title_full_unstemmed Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
title_short Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance.
title_sort circulating zonulin a marker of intestinal permeability is increased in association with obesity associated insulin resistance
url http://europepmc.org/articles/PMC3356365?pdf=render
work_keys_str_mv AT josemariamorenonavarrete circulatingzonulinamarkerofintestinalpermeabilityisincreasedinassociationwithobesityassociatedinsulinresistance
AT monicasabater circulatingzonulinamarkerofintestinalpermeabilityisincreasedinassociationwithobesityassociatedinsulinresistance
AT franciscoortega circulatingzonulinamarkerofintestinalpermeabilityisincreasedinassociationwithobesityassociatedinsulinresistance
AT wifredoricart circulatingzonulinamarkerofintestinalpermeabilityisincreasedinassociationwithobesityassociatedinsulinresistance
AT josemanuelfernandezreal circulatingzonulinamarkerofintestinalpermeabilityisincreasedinassociationwithobesityassociatedinsulinresistance